Thursday, December 15, 2011

Johnson & Johnson’s Baby Shampoo contain known carcinogens

Parents Alert; please read the following World Wire Report regarding baby shampoo from Johnson & Johnson. 

---------- Forwarded message ----------
From: "" <>
Date: Dec 15, 2011 1:51 PM
Subject: Multiple Carcinogens in Johnson & Johnson's Baby Shampoo
To: <>

Multiple Carcinogens in Johnson & Johnson's Baby Shampoo

CHICAGO, IL, December 15, 2011 –/WORLD-WIRE/– The Cancer
Prevention Coalition today congratulated the Campaign for Safe
Cosmetics for securing a 11/15/11 agreement with Johnson & Johnson
"for reducing or gradually phasing out – trace amounts of
potentially cancer-causing chemicals" from Baby Shampoo, "one of
its signature products." However, this agreement is limited and
restricted to the U.S. market.

"There are two carcinogenic ingredients in Johnson & Johnson's
Baby Shampoo, dioxane and quaternium 15," says Samuel S. Epstein,
M.D., who chairs the Cancer Prevention Coalition.

"Dioxane is a well-recognized contaminant in alcohol ethoxylates, a
group of four ingredients, laureths, oleths, polyethylene glycol and
polysorbates," Dr. Epstein explains. "Quaternium 15 is a precursor
of two carcinogens, formaldehyde and nitrosamine. Johnson & Johnson
has committed to "reducing or gradual phasing out" dioxane and
quaternium-15 in their U.S., but not in their international,

However limited, Dr. Epstein finds Johnson & Johnson's response to
be "in sharp and disturbing contrast to the silence of the Food and
Drug Administration (FDA)."

This federal agency has still failed to enforce the explicit
requirements of the 1938 Federal Food Drug and Cosmetic Act, Dr.
Epstein points out. This directs the FDA to require that "the label
of a cosmetic product shall bear a warning statement to prevent a
health hazard that may be associated with the product."

The regulatory failure of the FDA extends to its failure to respond to
the Cancer Prevention Coalition's extensively documented 1996
Citizen Petition "Seeking A Cancer Warning On Cosmetic Products
Containing (the carcinogen) Diethanolamine," says Dr. Epstein.

He says the FDA's regulatory failure extends still further to the
Coalition's 2008 Petition, "Seeking A (ovarian) Cancer Warning On
Talc Products Used By Premenopausal for Women's Genital Dusting."

Both Petitions, endorsed by leading cancer prevention experts,
requested the FDA to ban or suspend approval of these products which
still pose an "Imminent Hazard," or minimally to require their
labeling with a "Caution" or other such warning. However, the FDA
has still failed to respond.

"Concerns on the cancer risks of talc, dioxane, formaldehyde,
nitrosamine, and ethylene oxide, besides other prohibited and
restricted carcinogenic ingredients in cosmetics and personal care
products, are not new," Dr. Epstein says. "They were detailed in
my 2001 "Unreasonable Risk: How To Avoid Cancer From Cosmetics and
Personal Care Products," and 2009 "Healthy Beauty" books."

As published in the February 25, 2011 Science Insider editorial,
"Advancing Regulatory Science," FDA Commissioner, Dr. Margaret
Hamburg, claimed that FDA's regulations must be based on "better
predictive models – functional genomics, proteomics, and
metabolomics," rather than "high dose animal
studies – unchanged for decades."

"Dr. Hamburg's dismissal of standard carcinogenicity tests is
bizarre," says Dr. Epstein. "Their scientific validity has been
endorsed by other Federal regulatory agencies, the National Toxicology
Program, the International Agency for Research on Cancer, besides the
April 2010 President's Cancer Panel."

"Furthermore, as stipulated in the 1938 Federal Food Drug and
Cosmetic Act, the FDA is charged with regulating food, drugs, and
cosmetics based on standard toxicology and carcinogenicity tests.
Moreover, the FDA is not charged with, let alone capable of developing
irrelevant 'tests that incorporate the mechanistic underpinnings of
disease,'" Dr. Epstein points out.

As warned by Senator Edward Kennedy at the 1997 Senate Hearings on the
FDA Reform Bill, "The cosmetics industry has borrowed a page from
the playbook of the tobacco industry by putting profits ahead of
public health."

Dr. Epstein emphasizes, "This warning remains current."

Samuel S. Epstein, M.D. is professor emeritus of Environmental and
Occupational Medicine at the University of Illinois at Chicago School
of Public Health; Chairman of the Cancer Prevention Coalition; and
former President of the Rachel Carson Trust. His awards include the
1998 Right Livelihood Award and the 2005 Albert Schweitzer Golden
Grand Medal for International Contributions to Cancer Prevention. He
is the author of over 270 scientific articles and 20 books on the
causes and prevention of cancer, including the Unreasonable Risk Book:
How To Avoid Cancer from Cosmetics and Personal Care Products, The
Neways Story (2001, Environmental Toxicology), the groundbreaking The
Politics of Cancer (1979, Doubleday Books), Healthy Beauty: Your Guide
to Ingredients to Avoid and Products You Can Trust (2010, BenBella
Books), and National Cancer Institute And American Cancer Society:
Criminal Indifference to Cancer Prevention and Conflicts of Interest
(2011, Xlibris Publishing).


Samuel S. Epstein, M.D.

Chairman, Cancer Prevention Coalition

Professor emeritus Environmental & Occupational Medicine

University of Illinois at Chicago School of Public Health

Chicago, Illinois

Tel: 312-996-2297

Email: <javascript:location.href=>

Join CPC on Facebook

If you do not wish to receive this newswire anymore please click here,

To update your preferences and to unsubscribe visit
If you want to share ENS news you may forward an edition to someone

Powered by PHPlist, --

No comments:

Post a Comment

Thank you for visiting and taking time to share your thoughts.

My Best,